We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Wilfried Eberhardt

Wilfried E. E. Eberhardt MD

Department of Medical Oncology, West German Cancer Center, Ruhrlandklinik, University of Duisburg-Essen, Essen, Germany

Recent Contributions to PracticeUpdate:

  1. ASCO: Combination Immunotherapy for First-Line Treatment of Advanced Lung Cancer
  2. ASCO: Key Presentations on Small-Cell Lung Cancer
  3. ASCO: Key Presentations on Non-Small Cell Lung Cancer
  4. Recent Advances in Locally Advanced Lung Cancer
  5. ESMO: Survival Benefit From TKIs in Lung Cancer
  6. Immunotherapy Plus Chemo-Radiotherapy for Patients With Locally Advanced Lung Cancer
  7. Immunotherapy and TKIs in Stage III Lung Cancer
  8. ESMO 2018: Social and Behavioral Indicators of Lung Cancer Screening
  9. ESMO 2018: Genomic Landscape in Early Stage Lung Cancer
  10. Alectinib: A Step Forward in the Second-Line Treatment of ALK+ NSCLC

Most Read This Week

Recently Updated